NCT02090244View on ClinicalTrials.gov

Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2018

Study Completion Date

January 1, 2019

Conditions
Spinal Stenosis
Interventions
DRUG

Teriparatide

Daily injections with teriparatide 20 µg (PTH 1-34 (Forteo®)) during four weeks

Trial Locations (2)

Unknown

Ortopedkliniken, Kalmar

581 85

Ryggkliniken, US Linköping, Linköping

All Listed Sponsors
collaborator

Medical Research Council of Southeast Sweden

OTHER_GOV

lead

University Hospital, Linkoeping

OTHER

NCT02090244 - Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans? | Biotech Hunter | Biotech Hunter